Exhibit 99.1 FAT BRANDS INC. REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS Conference call and webcast today at 4:30 p.m. ET LOS ANGELES (November 5, 2025) – FAT (Fresh. Authentic. Tasty.) Brands Inc. (NASDAQ: FAT) ("FAT Brands" or the "Company") today reported financial results for the fiscal third quarter ended September 28, 2025. Andy Wiederhorn, Chairman and CEO of FAT Brands, said, "We delivered strong results across multiple areas in the third quarter, marking our best performance of the year to date. ...

Revenue Growth - Third quarter revenue reached $310.9 million, reflecting a 32% year-over-year growth[1] - Full-year 2025 revenue guidance raised to between $1.215 billion and $1.219 billion, indicating a 30% year-over-year growth[1] - Q4 2025 revenue guidance is projected between $331 million and $335 million, with a year-over-year growth rate of 23% to 24%[6] - For the nine months ended September 30, 2025, revenue was $883,824,000, a 32.4% increase from $667,300,000 in 2024[30] - Klaviyo's revenue for the three months ended September 30, 2025, was $310,880,000, representing a 32.1% increase from $235,094,000 in the same period of 2024[28] Profitability Metrics - Gross profit for Q3 2025 was $234.7 million, with a gross margin of 76%[5] - The gross profit for the same period was $234,737,000, with a gross margin of 75.5%, compared to a gross profit of $180,737,000 and a gross margin of 76.9% in 2024[36] - Non-GAAP operating income for Q3 2025 was $45.0 million, resulting in a non-GAAP operating margin of 14%[5] - For the three months ended September 30, 2025, Klaviyo reported a non-GAAP operating income of $44,979,000, compared to $33,710,000 in the same period of 2024, reflecting a year-over-year increase of 33.5%[38] - Non-GAAP net income for the three months ended September 30, 2025, was $55,389,000, up from $45,643,000 in 2024, representing a growth of 21.5%[40] Customer Growth - Customer base grew to over 183,000 as of September 30, 2025, up from over 157,000 a year prior[4] - The number of customers generating over $50,000 of ARR increased by 36% year-over-year, totaling 3,563 customers[4] Cash Flow and Assets - Cash from operating activities for Q3 2025 was $54.8 million, with free cash flow of $47.1 million[5] - Total current assets increased to $1,110,009,000 as of September 30, 2025, from $979,749,000 as of December 31, 2024[26] - Cash and cash equivalents rose to $980,267,000 as of September 30, 2025, compared to $881,473,000 at the end of 2024[26] - The company reported a net cash provided by operating activities of $54,760,000 for the three months ended September 30, 2025, compared to $38,784,000 in 2024[32] - Free cash flow for the three months ended September 30, 2025, was $47,055,000, compared to $34,246,000 in 2024, marking a year-over-year increase of 37.3%[45] Operating Expenses - Total operating expenses for the three months ended September 30, 2025, were $245,573,000, an increase from $194,015,000 in 2024, indicating a rise of 26.5%[43] - The non-GAAP total operating expenses for the nine months ended September 30, 2025, were $557,215,000, compared to $427,991,000 in 2024, representing an increase of 30.2%[54] - Stock-based compensation expense for the three months ended September 30, 2025, was $40,437,000, up from $31,557,000 in 2024[32] Net Loss and Improvement - Operating loss for the three months ended September 30, 2025, was $10,836,000, an improvement from a loss of $13,278,000 in 2024[28] - Klaviyo's net loss for the three months ended September 30, 2025, was $426,000, compared to a net loss of $1,345,000 in the same period of 2024[28] - The net loss for the three months ended September 30, 2025, was $426,000, significantly improved from a net loss of $1,345,000 in the same period of 2024[40] Liabilities - Klaviyo's total liabilities increased to $322,986,000 as of September 30, 2025, from $239,321,000 as of December 31, 2024[26] Operating Cash Flow Margin - Operating cash flow margin for the three months ended September 30, 2025, was 17.6%, compared to 16.5% in 2024, showing an improvement of 1.1 percentage points[45] - Non-GAAP operating margin for the three months ended September 30, 2025, was 14.5%, slightly up from 14.3% in 2024[38] Share Information - The number of shares used in non-GAAP per share calculations for the three months ended September 30, 2025, was 300,828,017 (basic), compared to 267,854,769 in 2024, indicating an increase of 12.3%[40]

Financial Performance - Total revenues for Q3 2025 were $11.1 billion, a 5% increase from $10.5 billion in Q3 2024[2] - Net income rose to $1.5 billion, reflecting a 9% increase compared to $1.4 billion in the prior year[2] - Adjusted EBITDA for the quarter was $2.7 billion, up 10% from $2.5 billion in Q3 2024[2] - The net income margin improved to 13.7%, an increase of 50 basis points from 13.2% in Q3 2024[2] - Net income for the nine months ended September 30, 2025, was $2,753 million, slightly down from $2,812 million in the same period of 2024[25] - Adjusted EBITDA for the nine months ended September 30, 2025, reached $5,653 million, an increase of 9.7% compared to $5,154 million in 2024[32] Shareholder Returns - The company returned $1.1 billion to shareholders year-to-date through share buybacks and dividends[3] - The company declared a quarterly dividend of $0.37 per share, representing a 6% increase year-over-year[13] - CRH is committed to returning cash to shareholders through share buybacks and dividends, with plans for timing and consistency[40] Acquisitions and Growth - CRH completed nine acquisitions totaling $2.5 billion during the quarter, contributing to growth[3] - The company is focused on acquisitions and divestitures, aiming for synergies and benefits from its M&A pipeline[40] Debt and Cash Position - Net debt increased to $15.0 billion as of September 30, 2025, compared to $10.5 billion at the end of 2024[12] - Net Debt as of September 30, 2025, was $(15,006) million, compared to $(10,532) million at December 31, 2024, showing an increase in cash position relative to debt[36] - Proceeds from debt issuances in the nine months ended September 30, 2025, amounted to $7,760 million, significantly higher than $3,452 million in the same period of 2024[27] - Cash paid for interest in the nine months ended September 30, 2025, was $494 million, compared to $372 million in 2024, reflecting an increase of 32.8%[27] Market Outlook - Looking ahead to 2026, CRH expects favorable market dynamics supported by public investment in infrastructure[14] - The company expects favorable market dynamics and demand across its platforms for 2025 and 2026[40] - CRH anticipates public investment in infrastructure and reindustrialization activities to positively impact its performance[40] Guidance and Expectations - CRH raised its Adjusted EBITDA guidance for 2025, indicating a strong outlook for the year[5] - The company updated its 2025 Adjusted EBITDA guidance to a mid-point of $7.65 billion, slightly up from the previous guidance of $7.6 billion[34] - Expectations for 2025 include net income, Adjusted EBITDA, diluted EPS, capital expenditures, assumed interest expense, and effective tax rate[40] Risks and Challenges - The company acknowledges risks such as economic conditions, competition, and regulatory changes that could impact future results[42] - CRH is aware of potential impacts from geopolitical conflicts and public sector funding delays for infrastructure programs[42] Sustainability - CRH emphasizes the importance of sustainable practices and products in response to investor and consumer sentiment[42]

Revenue Growth - Total revenues increased by 25.2% to $423.6 million compared to $338.2 million in Q3 2024[4] - Company-operated shops revenue rose by 27.4% to $392.8 million from $308.3 million in the same period of 2024[4] - Systemwide sales for the nine months ended September 30, 2025, were $1.64 billion, a 21.9% increase from $1.34 billion in the same period of 2024[26] - Full-year revenue guidance is raised to between approximately $1.61 billion and $1.615 billion[7] Same Shop Sales - Systemwide same shop sales grew by 5.7%, with company-operated same shop sales increasing by 7.4% year-over-year[4] - Same shop sales growth is now expected to be approximately 5% for the full year[7] - Same shop sales for company-operated shops increased by 7.4% in Q3 2025 compared to a 4.0% increase in Q3 2024[26] Net Income and Profitability - Net income reached $27.3 million, up from $21.7 million in Q3 2024[7] - Net income for the nine months ended September 30, 2025, was $88.1 million, compared to $60.1 million for the same period in 2024, reflecting a 46.6% year-over-year increase[27] - For the three months ended September 30, 2025, net income was $27,283,000, compared to $21,712,000 for the same period in 2024, representing a year-over-year increase of 25.5%[60] EBITDA - Adjusted EBITDA grew by 22.3% to $78.0 million compared to $63.8 million in the same period of 2024[7] - Adjusted EBITDA for the nine months ended September 30, 2025, was $229,912,000, or 19.2% of revenue, up from $181,461,000 and 19.3% in the same period of 2024[59] - The company expects continued growth in adjusted EBITDA and net income margins in the upcoming quarters, driven by operational efficiencies and market expansion strategies[58] Shop Openings and Growth - The company opened 38 new shops, 34 of which were company-operated, across 17 states[4] - Total system shop openings for 2025 are targeted to be 160, with an additional 175 planned for 2026[6] - The total number of company-operated shops increased to 759 by the end of Q3 2025, up from 645 at the end of Q3 2024, marking a 17.6% growth[26] Cash Flow and Financial Position - The company reported a net cash provided by operating activities of $215.9 million for the nine months ended September 30, 2025, compared to $184.2 million in 2024[21] - Cash and cash equivalents at the end of Q3 2025 were $267.2 million, down from $293.4 million at the beginning of the period[21] Cost Management - Selling, general, and administrative expenses for the three months ended September 30, 2025, were $65,289,000, which is 15.4% of total revenue, compared to $57,536,000 or 17.0% in 2024[60] - Adjusted selling, general, and administrative expenses were $57,639,000 for the three months ended September 30, 2025, representing 13.6% of total revenue, down from 14.9% in 2024[60] - Total organization realignment and restructuring costs for Q3 2025 amounted to $2,650,000, or 0.6% of revenue, down from $4,191,000 and 1.3% in Q3 2024[59] Shareholder Metrics - The weighted-average shares of Class A and Class D common stock outstanding - diluted increased to 127,379,000 in Q3 2025 from 114,252,000 in Q3 2024[61] - Adjusted net income per fully exchanged share of diluted common stock was $0.19 for the three months ended September 30, 2025, compared to $0.16 in 2024, indicating a 18.8% increase[61] Customer Engagement - Dutch Rewards transactions accounted for 71.8% of total transactions in Q3 2025, up from 67.2% in Q3 2024, indicating increased customer loyalty[26]

Investment Portfolio - As of September 30, 2025, the investment portfolio consisted of 363 real estate properties held for investment, down from 373 properties as of September 30, 2024[133]. - The company expects to continue diversifying its investment portfolio by tenant, facility type, and geography within the healthcare sector[121]. - The company’s portfolio consisted of 363 real estate properties held for investment, diversified across the U.S. and Canada[203]. Revenue and Income - Rental and related revenues for the three months ended September 30, 2025, were $85.4 million, a decrease of 10% compared to $94.6 million for the same period in 2024[134]. - Resident fees and services increased by 25% to $92.0 million for the three months ended September 30, 2025, compared to $73.7 million for the same period in 2024[138]. - Interest and other income rose by 31% to $12.7 million for the three months ended September 30, 2025, compared to $9.7 million for the same period in 2024[139]. - Rental and related revenues for the nine months ended September 30, 2025, were $281.2 million, down from $285.4 million in 2024, reflecting a $4.2 million decrease attributed to revenue write-offs and property disposals[154]. - Resident fees and services increased to $248.4 million for the nine months ended September 30, 2025, compared to $207.7 million in 2024, marking a $40.7 million increase due to new acquisitions and increased occupancy[156]. - Interest and other income rose to $33.1 million for the nine months ended September 30, 2025, up from $27.7 million in 2024, reflecting a $5.3 million increase driven by lease termination income and late fees[157]. Expenses - Depreciation and amortization expense increased to $48.5 million for the three months ended September 30, 2025, up from $42.7 million in the same period of 2024, reflecting a net increase of $5.8 million[140]. - Senior Housing - Managed portfolio operating expenses rose to $65.9 million for the three months ended September 30, 2025, an increase of $11.7 million from $54.2 million in 2024, driven by acquisitions and increased occupancy[143]. - General and administrative expenses were $12.6 million for the three months ended September 30, 2025, slightly up from $12.4 million in 2024, mainly due to increased legal and professional fees[145]. - Senior Housing - Managed portfolio operating expenses increased by $25.5 million to $179.8 million for the nine months ended September 30, 2025, compared to $154.3 million for the same period in 2024[161]. - General and administrative expenses rose by $0.8 million to $37.8 million for the nine months ended September 30, 2025, from $37.0 million in 2024, primarily due to increased compensation and legal fees[162]. Impairment and Gains - Impairment of real estate recognized was $6.7 million for the nine months ended September 30, 2025, down from $18.5 million in 2024, indicating a $11.8 million decrease[158]. - A net gain of $5.5 million was recognized from the sale of real estate during the nine months ended September 30, 2025, in contrast to a net loss of $4.0 million in 2024[167]. - The company reported a net loss of $4.4 million on sales of real estate for the three months ended September 30, 2025, compared to a net loss of $5.7 million in the same period of 2024[150]. Debt and Financing - The company redeemed all $500.0 million of 5.125% senior unsecured notes due 2026 on July 31, 2025[130]. - The company recognized a $1.2 million loss on extinguishment of debt during the nine months ended September 30, 2025, while no loss was recorded in the same period of 2024[165]. - The company established an At-The-Market Common Stock Offering Program with a gross sales price of up to $750.0 million on August 5, 2025[131]. - The company expects to finance future investments in properties using proceeds from the ATM Program, among other sources[181]. Cash Flow and Liquidity - As of September 30, 2025, the company had approximately $1.1 billion in liquidity, including $200.6 million in cash and cash equivalents and $717.8 million available under its Revolving Credit Facility[174]. - The company utilized the forward feature of the Prior ATM Program to sell 15.3 million shares at an initial weighted average price of $17.69 per share, resulting in net proceeds of $194.9 million for the nine months ended September 30, 2025[177]. - Net cash used in investing activities was $261.4 million, including $301.6 million for the acquisition of seven facilities and $24.2 million for additions to real estate[185]. - The company paid dividends of $214.7 million during the nine months ended September 30, 2025, with a quarterly cash dividend of $0.30 per share declared on November 5, 2025[199]. - As of September 30, 2025, the company had net cash provided by operating activities of $261.2 million, primarily from rental payments and resident fees[184]. Market Conditions and Regulations - Economic conditions, including increases in interest rates and inflation, are expected to impact the company's operations and financial position[124]. - On July 31, 2025, CMS announced a 3.2% estimated net increase in Medicare rates for skilled nursing facilities for fiscal year 2026, effective October 1, 2025[208]. - The estimated net increase in Medicare rates for skilled nursing facilities for fiscal year 2025 was 4.2%, effective October 1, 2024[207]. - The Minimum Staffing Standards were vacated by a federal judge on April 7, 2025, and a 10-year moratorium on enforcement was signed into law on July 4, 2025[206]. - The Assessment Requirements for long-term care facilities remain in effect, which may exacerbate staffing challenges[206]. - No tenant relationship represented 10% or more of the company's total revenues for the three and nine months ended September 30, 2025[204]. - There have been no material changes to the quantitative and qualitative disclosures about market risk since the 2024 Annual Report[209].

Exhibit 99.1 Quantum-Si Reports Third Quarter 2025 Financial Results Announces Successful Sequencing on Prototype Proteus Unit, Development Program Remains On-Track BRANFORD, Conn. -- (BUSINESS WIRE) -- November 5, 2025 -- Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single- molecule detection, today announced financial results for the third quarter ended September 30, 2025. Press Release Highlights Total op ...

Exhibit 99.1 Noodles & Company Announces Third Quarter 2025 Financial Results Broomfield, Colo., November 5, 2025 (GLOBE NEWSWIRE) - Noodles & Company (Nasdaq: NDLS) today announced financial results for its third quarter ended September 30, 2025. Key highlights for the third quarter of 2025 versus the third quarter of 2024 include: Joe Christina, Chief Executive Officer of Noodles & Company, remarked, "I am very pleased with our recent sales trends, with comparable sales up 4% in the third quarter, which s ...

Financial Performance - Total revenues for Q3 2025 were $1,239.7 million, an increase from $1,225.6 million in Q2 2025, and $1,193.0 million in Q3 2024, reflecting a year-over-year growth of 3.9%[7] - Earned premiums for Q3 2025 reached $1,133.3 million, slightly up from $1,130.8 million in Q2 2025 and significantly higher than $1,087.9 million in Q3 2024, indicating a year-over-year increase of 4.2%[7] - Net (loss) income attributable to Kemper Corporation for Q3 2025 was $(21.0) million, compared to a profit of $72.6 million in Q2 2025 and $99.7 million in Q3 2024, showing a significant decline[7] - Adjusted consolidated net operating income for Q3 2025 was $20.4 million, down from $84.1 million in Q2 2025 and $106.4 million in Q3 2024, reflecting a decrease of 75.8% year-over-year[7] - Total expenses for the three months ended September 30, 2025, were $1,272.8 million, an increase from $1,138.1 million in the prior quarter, marking an 11.8% rise[13] - The company reported a net loss attributable to Kemper Corporation of $21.0 million for the three months ended September 30, 2025, compared to a net income of $72.6 million in the previous quarter[29] - Adjusted Consolidated Net Operating Income for the three months ended September 30, 2025, was $20.4 million, a decrease from $105.0 million for the same period in 2024[65] Assets and Liabilities - Total assets as of September 30, 2025, were $12,443.4 million, a decrease from $12,601.1 million at the end of Q2 2025[11] - Total liabilities decreased to $9,721.8 million as of September 30, 2025, down from $10,102.6 million a year earlier, a reduction of 3.8%[17] - Total shareholders' equity was $2,721.6 million as of September 30, 2025, compared to $2,770.4 million a year prior, indicating a decline of 1.8%[17] - The debt to total capitalization ratio was 25.7% as of September 30, 2025, up from 24.2% in Q2 2025, suggesting an increase in leverage[11] - Long-term debt remained stable at approximately $943.1 million as of September 30, 2025, consistent with previous quarters[17] Investment Performance - Total investments as of September 30, 2025, amounted to $8,602.6 million, a decrease from $8,645.5 million at the end of the previous quarter[15] - Net investment income for the nine months ended September 30, 2025, was $301.9 million, slightly down from $304.5 million in the same period last year[49] - The company reported net realized investment gains of $3.9 million for the three months ended September 30, 2025, compared to a loss of $0.1 million in the previous quarter[49] - The company experienced a net realized investment loss of $4.7 million for the nine months ended September 30, 2025, compared to a loss of $9.2 million in the same period of 2024[19] Insurance Operations - Insurance reserves increased to $6,123.6 million as of September 30, 2025, compared to $5,900.0 million in Q2 2025, indicating a rise in claims reserves[11] - Policyholders' benefits and incurred losses for the three months ended September 30, 2025, were $924.6 million, compared to $829.1 million in the previous quarter, reflecting an increase of 11.5%[13] - The Combined Ratio for Q3 2025 was reported at 104.8%, compared to 95.4% in Q2 2025, showing a significant deterioration in underwriting performance[37] - Current Year Non-catastrophe Losses and LAE Ratio for Q3 2025 was 78.5%, up from 72.3% in Q2 2025, indicating higher loss costs[37] Shareholder Information - Book value per share decreased to $45.38 as of September 30, 2025, down from $46.45 in Q2 2025, indicating a decline in shareholder equity value[11] - Dividends paid to shareholders per share remained stable at $0.32 for Q3 2025, consistent with the previous quarter[11] - Cash Dividends Paid were $19.7 million, down from $20.8 million in the previous quarter, a decrease of 5.3%[23] - The return on shareholders' equity for Q3 2025 was (3.0)%, a significant drop from 9.9% in Q2 2025, reflecting poor financial performance[11] Operational Changes - The company launched a restructuring program in Q3 2025 aimed at achieving operational and organizational efficiencies, with ongoing evaluations through 2027[62] - The company aims to fully exit its Preferred Insurance business, which is classified under Non-Core Operations[62] Segment Performance - Specialty Property & Casualty Insurance earned premiums reached $1,017.3 million, compared to $1,010.8 million in the prior quarter, reflecting a growth of 0.5%[27] - Total Segment Adjusted Operating Income decreased to $30.0 million from $113.2 million in the previous quarter, representing a decline of 73.5%[29] - Net Premiums Written for Q3 2025 reached $982.2 million, a decrease from $1,001.5 million in Q2 2025[37] - Total Revenues for the Specialty Property & Casualty Insurance Segment reached $252.4 million in Q3 2025, compared to $206.8 million in Q3 2024, reflecting a 22.0% increase[41]

Revenue Performance - Total revenue for Q3 2025 was $229.0 million, an increase of $48.4 million or 26.8% year-over-year[2]. - Total revenue for the three months ended September 30, 2025, was $229,039 thousand, a 26.7% increase from $180,688 thousand in the same period of 2024[20]. - Home health and hospice revenue for the nine months ended September 30, 2025, reached $499,455 thousand, up 32.3% from $377,463 thousand in 2024[25]. - Total revenue for the nine months ended September 30, 2025, was $658,382,000, a 30.0% increase from $506,348,000 in the same period of 2024[31]. Segment Performance - Home Health and Hospice Services segment revenue for Q3 2025 was $173.6 million, an increase of $37.9 million or 27.9% year-over-year[2]. - Senior Living Services segment revenue for Q3 2025 was $55.5 million, an increase of $10.5 million or 23.2% year-over-year[2]. - Senior living revenue for the three months ended September 30, 2025, was $55,474 thousand, reflecting a 23.2% increase from $45,016 thousand in 2024[27]. - Home Health and Hospice segment revenue for Q3 2025 was $173,545, an increase of 28% from $135,672 in Q3 2024[41]. - Senior Living segment revenue for Q3 2025 was $53,880, up 20% from $45,016 in Q3 2024[41]. Admissions and Census - Total home health admissions for Q3 2025 were 20,426, an increase of 5,433 or 36.2% year-over-year[2]. - Hospice average daily census for Q3 2025 was 4,044, an increase of 600 or 17.4% year-over-year[2]. - Total home health admissions increased by 36.2% to 20,426 for the three months ended September 30, 2025, compared to 14,993 in 2024[24]. - The average daily census for hospice services increased by 17.4% to 4,044 for the three months ended September 30, 2025, compared to 3,444 in 2024[24]. Financial Guidance and Projections - Updated 2025 annual revenue guidance is anticipated to be between $911.4 million and $948.6 million[4]. - Full year 2025 adjusted earnings per diluted share is anticipated to be between $1.14 and $1.18, representing a growth of 23.4% from 2024[5]. - Full year 2025 adjusted EBITDA is anticipated to be between $70.9 million and $73.8 million[4]. Income and Earnings - Adjusted net income for Q3 2025 was $10.4 million, an increase of $2.3 million or 27.6% year-over-year[2]. - Non-GAAP net income for Q3 2025 was $10,421,000, compared to $8,167,000 in Q3 2024, representing a 27.5% increase[32]. - Adjusted diluted earnings per share for Q3 2025 was $0.30, up from $0.26 in Q3 2024[32]. - Consolidated Adjusted EBITDA for Q3 2025 was $17,347,000, compared to $15,149,000 in Q3 2024, indicating a 14.5% increase[36]. Assets and Liabilities - Total assets as of September 30, 2025, were $753,641 thousand, an increase from $679,521 thousand at December 31, 2024[16]. - Total current liabilities increased to $109,352 thousand as of September 30, 2025, from $101,700 thousand at December 31, 2024[16]. - Total equity as of September 30, 2025, was $343,043 thousand, up from $311,965 thousand at December 31, 2024[16]. Operational Metrics - Average Medicare revenue per 60-day completed episode for home health services was $3,793 for the three months ended September 30, 2025, a 2.9% increase from $3,687 in 2024[24]. - Occupancy rate improved to 81.8% in Q3 2025, up from 80.2% in Q3 2024, reflecting a 1.6% increase[28]. - Average monthly revenue per occupied unit rose to $5,136 in Q3 2025, a 7.2% increase from $4,790 in Q3 2024[28]. - Average monthly revenue per occupied unit for the nine months ended September 30, 2025, was $5,180, an 8.9% increase from $4,758 in the same period of 2024[28]. Acquisitions and Corporate Strategy - The company completed the acquisition of 54 home health, hospice, and home care operations from UnitedHealth Group and Amedisys on October 1, 2025[3]. - The company is focusing on transitioning operations and has incurred costs related to acquisitions and unusual charges, impacting overall financial performance[43].

Revenue Growth - Total revenues for the three months ended September 30, 2025, were $375,549, up 12.0% compared to the same period in 2024, and $1,110,197 for the nine months ended September 30, 2025, up 10.7%[134] - Subscription revenues for the three months ended September 30, 2025, were $344,293, up 13.5%, and $1,020,063 for the nine months ended September 30, 2025, up 12.4%[134] - Annual Recurring Revenue (ARR) was $1,405,236 as of September 30, 2025, representing a constant currency ARR growth rate of 10.5%[134] - The last twelve-month recurring revenues increased by $155,106 million, primarily due to growth in ARR and new account additions[176] - Total revenues for Q3 2025 were $375,549, compared to $335,173 in Q3 2024, reflecting an increase of 12.0%[190] - Subscription revenues for Q3 2025 reached $344,293, a rise from $303,239 in Q3 2024, marking a growth of 13.6%[190] - The company reported a total revenue of $1,110,197 for the nine months ended September 30, 2025, compared to $1,003,273 for the same period in 2024, which is a 10.7% increase[190] Regional Performance - Revenues from the Americas increased by 11.8% to $196,345 for the three months ended September 30, 2025, and by 9.9% to $589,379 for the nine months ended September 30, 2025[145] - EMEA revenues increased by 13.2% to $107,887 for the three months ended September 30, 2025, and by 12.0% to $320,306 for the nine months ended September 30, 2025[145] - APAC revenues increased by 11.0% to $71,317 for the three months ended September 30, 2025, and by 10.6% to $200,512 for the nine months ended September 30, 2025[145] - The Americas region generated $196,345 in revenue for Q3 2025, up from $175,609 in Q3 2024, representing an increase of 11.5%[190] - EMEA revenues for Q3 2025 were $107,887, compared to $95,343 in Q3 2024, indicating a growth of 13.5%[190] - APAC revenues for Q3 2025 reached $71,317, an increase from $64,221 in Q3 2024, reflecting a growth of 11.5%[190] Operating Income and Expenses - Operating income for the three months ended September 30, 2025, was $84,497, compared to $68,630 for the same period in 2024, and $284,111 for the nine months ended September 30, 2025, compared to $240,738 in 2024[134] - Cost of revenues for the three months ended September 30, 2025, was $72,195, an increase of 11.4% compared to the same period in 2024, and $206,630 for the nine months ended September 30, 2025, up 8.8%[153] - Research and development expenses for the three months ended September 30, 2025, increased by 12.4% to $78,751 million compared to $70,068 million in 2024[156] - Selling and marketing expenses for the same period rose by 11.0% to $72,107 million, driven by headcount-related costs and promotional expenses[158] - Total operating expenses for the nine months ended September 30, 2025, were $619,456 million, an increase of 8.2% from $572,680 million in 2024[156] - Adjusted Operating Income Less Stock-Based Compensation (AOI less SBC) for Q3 2025 was $104,026, compared to $89,524 in Q3 2024, representing a 16.3% increase[188] - Adjusted Operating Income (AOI) for the nine months ended September 30, 2025, was $389,966, up from $354,250 in the same period of 2024, indicating a growth of 10.1%[188] Cash Flow and Financial Position - Cash flows from operations were $396,876 for the nine months ended September 30, 2025, compared to $353,660 for the same period in 2024[134] - Net cash provided by operating activities for the nine months ended September 30, 2025, was $396,876, an increase of 12.2% from $353,660 in 2024[195] - Cash and cash equivalents as of September 30, 2025, totaled $165,411, significantly higher than $64,009 at the end of 2024[193] - Long-term debt decreased to $1,247,378 as of September 30, 2025, from $1,388,088 at the end of 2024[199] - Net cash used in investing activities was $13,774 for the nine months ended September 30, 2025, a significant decrease from $135,680 in 2024[195] - The company had $1,299,850 available under the Credit Facility as of September 30, 2025, and was in compliance with all covenants[199] Shareholder Returns - The company repurchased 1,457,454 shares for $65,029 during the nine months ended September 30, 2025, compared to 912,737 shares for $45,769 in 2024[202] - The quarterly dividend per share increased to $0.07 in 2025 from $0.06 in 2024, resulting in higher dividend payments of $9,771[198] - Quarterly dividends paid were $0.07 per share for the nine months ended September 30, 2025, compared to $0.06 per share for the same period in 2024[205] - Future dividend payments will depend on the discretion of the Board of Directors and various factors including operational results and financial condition[205] Tax and Interest - Interest expense, net decreased by 41.6% to $(2,727) million for the three months ended September 30, 2025, primarily due to lower average debt outstanding[162] - The effective tax rate for the three months ended September 30, 2025, was 31.4%, up from 28.1% in 2024, mainly due to increased discrete tax expenses[164] - The company anticipates favorable impacts on cash paid for income taxes in 2025 and 2026 due to the One Big Beautiful Bill Act, particularly for domestic R&D expenses[166] Customer Metrics - The account retention rate remained stable at 99% for both September 30, 2025, and 2024, indicating strong customer loyalty[168] - Recurring revenues dollar-based net retention rate was 109% for both periods, demonstrating effective revenue growth from existing accounts[168] Financial Reporting Practices - The company uses non-GAAP financial measures to evaluate operational performance and assist in internal budgeting and forecasting[186] - There have been no material changes in market risk exposure as described in the 2024 Annual Report on Form 10-K[206]